Laser eye treatment may impact corneal cells, new study warns
NCT ID NCT07157553
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether argon laser treatment for advanced diabetic eye disease (proliferative diabetic retinopathy) changes the number of cells in the cornea. Researchers will measure corneal cell density before and after laser treatment in 45 patients. The goal is to see if the laser causes any harm to the cornea, which is important for keeping vision clear.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- argon laser panretinal photocoagulation
- What this could lead to
- If it works, this could help doctors understand if laser treatment for diabetic eye disease harms the cornea, leading to safer procedures.
- What could go wrong
- This is a small, early observational study with only 45 people. It measures a cell count, not vision outcomes, so the real-world impact is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANRETINAL PHOTOCOAGULATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing eye injections: could 3, 7, or 14 days before surgery matter?
- Eye injections could clear Diabetes-Related bleeding and save sight
- Eye injection may ease pain of laser surgery for diabetic patients
- New study aims to catch diabetic eye disease before it steals sight
- Could your genes predict blindness from diabetes?
- New laser approach aims to save sight in diabetic patients